L-Carbocisteine is an emmenagogue mucolytic that is used to treat COPD and other illnesses that cause mucus thickness to increase. Shortness of breath and cough are frequent symptoms of COPD11 and other respiratory disorders characterized by increased mucus production. Due to the proliferation and storage of viruses and bacteria in thick bronchial mucus, people with COPD have a higher risk of lung infection. Carbocisteine is a mucolytic medication that reduces the viscosity of mucus, allowing it to be evacuated, and so relieves respiratory symptoms and infections.

L-carbocisteine reduces hydrogen peroxide damage to cells via increasing protein kinase B phosphorylation, implying that carbocisteine may well have antioxidant properties and prevent lung cell death. There is some indication that carbocisteine inhibits the NF-B and ERK1/2 MAPK signaling pathways, as well as other inflammatory pathways, lowering TNF-alpha-induced inflammation in the lungs. L-carbocisteine lowers intracellular adhesion molecules, which inhibits rhinovirus infection and hence reduces airway inflammation, according to an in-vitro study. It prevents lung infections by blocking bacterial adhesion to cells. Fucomucins, sialomucins, and sulfomucins are glycoproteins that control the viscoelastic characteristics of bronchial mucus. Patients with COPD have higher levels of fucomucins in their sputum. Carbocisteine reduces mucus viscosity by restoring the balance between sialomucins and fucomucins, most likely by intracellular stimulation of the sialyltransferase enzyme.

It can be purchased at a variety of prices from a variety of manufacturers and dealers. Based on the drugstore you visit, L-Carbocisteine oral capsule 150 mg costs roughly $25 for a supply of 30 capsules. Prices are solely valid for cash-paying customers and do not applicable to insurance policies. Pharmaceutical corporations generally support patient assistance programs (PAPs), which provide free or subsidized drugs to low-income, unemployed, or poorly patients who meet certain criteria.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of L-Carbocisteine offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of L-Carbocisteine. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where L-Carbocisteine is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen L-Carbocisteine manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.